Dietary supplement recalled over undeclared ingredients.

www.med-art.com

Medscape (8/31, Hitt) reports that drug manufacturer, Samantha Lynn, Inc. has issued a "voluntary recall of 500 lots" of Reumofan Plus. According to an FDA Safety Alert, a sample analysis "found the product to contain methocarbamol and diclofenac." The affected drugs "may include lot number 99515 ex096, with an expiration date of 2016" and was "distributed via the Internet...between February 2012 and June 2012." Although the manufacturer has not yet received any adverse events related to the dietary supplement, which is "used as a treatment for muscle pain, arthritis, osteoporosis, bone cancer, and other conditions," the FDA warned that "use of this product could result in life-threatening hypersensitivity reactions and anaphylaxis and could cause a temporary and reversible increase in [central nervous system] depression."